Clare Hutton & Peter Colley
Hull & East Yorkshire Hospitals NHS Trust
Clare qualified in 2000 from University of Leeds with a BHSc (Hons) in Therapy Radiography. Commencing her career in London shortly returning to Hull where she had completed her clinical training and has continued to develop through her 18 year career. Clare was the lead Therapy Radiographer for IMRT, this interest led her to commence postgraduate education starting with a module specifically for IMRT; she was also awarded with a grant from her Trust to gain clinical experience in Palo Alto, San Francisco. Clare completed her PGDip in Radiotherapy & Oncology from Sheffield Hallam University in 2009. Clare has continued her postgraduate education and in 2015 graduated from the University of Leeds with an MSc in Leadership & Management in Health & Social Care which has helped her lead the radiotherapy service and recent IMRT advances in her current role as Radiotherapy Manager.
Peter is a registered Higher Specialist Scientist and the Consultant Physicist Lead for Radiotherapy Physics in Hull and has over 18 years of experience working in Radiotherapy Physics and with quality improvement systems. He has worked in various senior physics roles including the Oncology Information Systems Lead Principal Physicist, and the post of Principal Physicist Lead for Radiotherapy Treatment Planning, before moving into his current role.
The Implementation & Development of IMRT in Hull
The seminar will explain the local implementation and development of IMRT. Demonstrating how the service gained the 24% IMRT national target and how this has been sustained. The seminar will demonstrate the excellent MDT working relationships including the changes to patient specific QA to enable patients to commence treatment within 28 days. This will include the review of equipment replacement the service has experienced since the central investment in Radiotherapy equipment.
EVEN MORE SEMINARS
Professor A. Graham Pockley multimmune GmbH / Nottingham Trent University
A new era of cancer therapeutics?
Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd NHS Lothian, Scotland
Optimising Surgical Resection in Low Grade Glioma Patients
Nirmesh Patel Cambridge Cancer Genomics
Monitoring cancer evolution through smart genomics and liquid biopsies
Nizar Asadi Royal Brompton & Harefield NHS Foundation Trust
Thoracic surgery in the treatment of lung cancer
Emlyn Samuel Cancer Research UK
Brexit: getting the best outcome for research and patients